$17.70
0.0% Today
as of Jul 22, 16:53 ET
Last 30 days
Recent Press Releases & News
PROCEPT BioRobotics® to Report Second Quarter 2026 Financial Results on August 4th, 2026
Truist Downgrades PROCEPT BioRobotics to Hold From Buy, Lowers Price Target to $25 From $30
Evercore Initiates PROCEPT BioRobotics (PRCT) At “Outperform,” Cites Aquablation Growth Potential
Overview
52-week range
$19
$67
0% of range
Avg surprise (last 2)
+11.4%
Avg reaction (last 1)
-5.6%
0% positive
Latest IV / EM
102%
EM ±23.4% · $18 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Mar 31, 2026 | Mar 2026 | $-0.56 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $-0.38 | — | — | — | — | financials |
| Wed Aug 6, 2025 | Jun/2025 | $-0.35 | $-0.41 | +14.6% | — | — | earnings |
| Thu Apr 24, 2025 | Mar/2025 | $-0.45 | $-0.49 | +8.2% | — | -5.6% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.40 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.50 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.51 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.51 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.56 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Tue Aug 4, 2026 | Jun/2026 | AMC | -$0.46 | -$0.35 | -31.4% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $83M | — | $83M | $79M | $69M | — | $58M | $53M |
| Cost of revenue | $29M | — | $29M | $27M | $25M | — | $21M | $22M |
| Gross profit | $54M | — | $54M | $52M | $44M | — | $37M | $31M |
| Operating income | $-33M | — | $-23M | $-22M | $-27M | — | $-22M | $-27M |
| Net income | $-32M | — | $-21M | $-20M | $-25M | — | $-21M | $-26M |
| EPS (diluted) | $-0.56 | — | $-0.38 | $-0.35 | $-0.45 | — | $-0.40 | $-0.50 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $246M | $287M | $294M | $303M | $316M | $334M | $197M | $214M |
| Inventory | $78M | $71M | $67M | $67M | $62M | $56M | $51M | $44M |
| Total current assets | $428M | $450M | $455M | $458M | $466M | $482M | $323M | $322M |
| Total assets | $487M | $508M | $512M | $513M | $519M | $534M | $374M | $374M |
| Long-term debt | $52M | $52M | $52M | $52M | $51M | $51M | $51M | $51M |
| Total liabilities | $139M | $142M | $131M | $127M | $130M | $132M | $133M | $123M |
| Total equity | $348M | $366M | $380M | $386M | $389M | $402M | $241M | $252M |